References
- Aghanoori MR, Mirzaei B, Tavallaei M (2014). MiRNA molecular profiles in human medical conditions: connecting lung cancer and lung development phenomena. Asian Pac J Cancer Prev, 15, 9557-65. https://doi.org/10.7314/APJCP.2014.15.22.9557
- Ahmed FE (2007). Role of miRNA in carcinogenesis and biomarker selection: a methodological view. Expert Rev Mol Diagn, 7, 569-603. https://doi.org/10.1586/14737159.7.5.569
- Bauer KM, Hummon AB (2012). Effects of the miR-143/- 145 microRNA cluster on the colon cancer proteome and transcriptome. J Proteome Res, 11, 4744-54. https://doi.org/10.1021/pr300600r
- Bentwich I, Avniel A, Karov Y, et al (2005). Identification of hundreds of conserved and nonconserved human microRNAs. Nat Gen, 37, 766-770. https://doi.org/10.1038/ng1590
- Berber U, Yilmaz I, Narli G et al (2014). miR-205 and miR- 200c: Predictive Micro RNAs for Lymph Node Metastasis in Triple Negative Breast Cancer. J Breast Cancer, 17, 143-8. https://doi.org/10.4048/jbc.2014.17.2.143
- Bozkurt O, Inanc M, Turkmen E, et al (2014). Clinicopathological characteristics and prognosis of patients according to recurrence time after curative resection for colorectal cancer. Asian Pac J Cancer Prev, 15, 9277-81. https://doi.org/10.7314/APJCP.2014.15.21.9277
- Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nat Rev Cancer, 6, 857-66. https://doi.org/10.1038/nrc1997
- Carthew RW, Sontheimer EJ (2009). Origins and mechanisms of miRNAs and siRNAs. Cell, 136, 642-655. https://doi.org/10.1016/j.cell.2009.01.035
- Christensen LL, Tobiasen H, Holm A, et al (2013). MiRNA-362- 3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer. Int J Cancer, 133, 67-78. https://doi.org/10.1002/ijc.28010
- Della Vittoria Scarpati G, Calura E, Di Marino M et al (2014). Analysis of differantial miRNA expression in primary tumor and stroma of colorectal cancer patients. Biomed Res Int, 2014, 840921.
- Diaz R, Silva J, Garcia JM, et al (2008). Deregulated expression of miR-106a predicts survival in human colon cancer patients. Genes Chromosomes Cancer, 47, 794-802. https://doi.org/10.1002/gcc.20580
- Farh KK, Grimson A, Jan C, et al (2005). The widespread impact of mammalian microRNAs on mRNA repression and evolution. Science, 310, 1817-21. https://doi.org/10.1126/science.1121158
- Farooqi AA, Qureshi MZ, Coskunpinar E et al (2014). MiR-421, miR-155 and miR-650: emerging trends of regulation of cancer and apoptosis. Asian Pac J Cancer Prev, 15, 1909-12. https://doi.org/10.7314/APJCP.2014.15.5.1909
- Fritzmann J, Morkel M, Besser D, et al (2009). A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential. Gastroenterol, 137, 165-75. https://doi.org/10.1053/j.gastro.2009.03.041
- Huang Z, Huang D, Ni S, et al (2010). Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer, 127, 118-26. https://doi.org/10.1002/ijc.25007
- Karaayvaz M, Pal T, Song B, et al (2011). Prognostic significance of miR-215 in colon cancer. Clin Colorectal Cancer, 10, 340-7. https://doi.org/10.1016/j.clcc.2011.06.002
- Kulda V, Pesta M, Topolcan O, et al (2010). Relevance of miR- 21 and miR-143 expression in tissue samples of colorectal carcinoma and its liver metastases. Cancer Genet Cytogenet, 200, 154-160. https://doi.org/10.1016/j.cancergencyto.2010.04.015
- Link A, Balaguer F, Shen Y et al (2010). Fecal microRNAs as novel biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers Prev, 19, 1766-74. https://doi.org/10.1158/1055-9965.EPI-10-0027
-
Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real time qantitative PCR and the 2-
${\Delta}{\Delta}CT$ method. Methods, 25, 402-8. https://doi.org/10.1006/meth.2001.1262 - Ma ZB, Kong XL, Cui G, et al (2014). Expression and clinical significance of miRNA-34a in colorectal cancer. Asian Pac J Cancer Prev, 15, 9265-70. https://doi.org/10.7314/APJCP.2014.15.21.9265
- Mo ZH, Wu XD, Li S, Fei BY, Zhang B. Expression and clinical significance of microRNA-376a in colorectal cancer. Asian Pac J Cancer Prev, 15, 9523-7.
- Nakajima G, Hayashi K, Xi Y, et al (2006). Non-coding microRNAs hsa-let-7g and hsa-miR-181b are associated with chemoresponse to S-1 in colon cancer. Cancer Genomics Proteomics, 3, 317-24.
- Omranipour R, Mahmoodzadeh H, Safavi F (2014). Prevalence of local recurrence of colorectal cancer at the Iranian Cancer Institute. Asian Pac J Cancer Prev, 15, 8587-9. https://doi.org/10.7314/APJCP.2014.15.20.8587
- Rosenfeld N, Aharonov R, Meiri E, et al (2008). MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol, 26, 462-9. https://doi.org/10.1038/nbt1392
- Schepeler T, Reinert JT, Ostenfeld MS, et al (2008). Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res, 68, 6416-24. https://doi.org/10.1158/0008-5472.CAN-07-6110
- Slaby O, Svoboda M, Fabian P, et al (2007). Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinico-pathologic features of colorectal cancer. Oncology, 72, 397-402. https://doi.org/10.1159/000113489
- Soerjomataram I, Lortet-Tieulent J, Parkin DM, et al (2012). Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet, 380, 1840-50. https://doi.org/10.1016/S0140-6736(12)60919-2
- Su SF, Chang YW, Andreu-Vieyra C, et al (2013). miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer. Oncogene, 32, 4694-701. https://doi.org/10.1038/onc.2012.483
- Xi Y, Formentini A, Chien M, et al (2006). Prognostic values of microRNAs in colorectal cancer. Biomark Insights, 2, 113-21.
- Wang LL, Du LT, Li J, et al (2014). Decreased expression of miR-133a correlates with poor prognosis in colorectal cancer patients. World J Gastroenterol, 20, 11340-6. https://doi.org/10.3748/wjg.v20.i32.11340
- Wu WK, Law PT, Lee CW, et al (2011). MicroRNA in colorectal cancer: from benchtop to bedside. Carcinogenesis, 32, 247-53. https://doi.org/10.1093/carcin/bgq243
- Zhang W, Winder T, Ning Y, et al (2011). A let-7 microRNAbinding site polymorphism in 3'-untranslated region of KRAS gene predicts response in wild-type KRAS patients with metastatic colorectal cancer treated with cetuximab monotherapy. Ann Oncol, 22, 104-9. https://doi.org/10.1093/annonc/mdq315
- Zhang GJ, Xiao HX, Tian HP, et al (2013). Upregulation of microRNA-155 promotes the migration and invasion of colorectal cancer cells through the regulation of claudin-1 expression. Int J Mol Med, 31, 1375-80.
Cited by
- Colorectal adenoma and carcinoma specific miRNA profiles in biopsy and their expression in plasma specimens vol.9, pp.1, 2017, https://doi.org/10.1186/s13148-016-0305-3
- MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma vol.38, pp.3, 2018, https://doi.org/10.1042/BSR20180668